Determination of phenytoin and its major metabolite in human serum by MEKC

Journal of Chromatographic Science

Volumn 47, Issue 10, 2009, Pages 877-880

  Jabbaribar, F ^a,b   Mortazavi, S A ^b   Jouyban, A ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70450202082     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/47.10.877     Document Type: Article

References (14)

1. A. Warner, M. Privitera, and D. Bates. Standards of laboratory practice: antiepileptic drug monitoring. Clin. Chem. 44: 1085-1095 (1998).
2. G.J. Conard, H. Jeffay, L. Boshes, and A.D. Steinberg. Levels of 5,5-diphenylhydantoin and its major metabolite in human serum, saliva, and hyperplastic gingiva. J. Dent. Res. 53: 1323-1329 (1974).
3. R.J. Sawchuk and L.L. Cartier, Liquid-chromatographic method for simultaneous determination of phenytoinand 5-(4-Hydroxyphenyl)-5-phenylhydantoin in plasma and urine. Clin. Chem. 26: 835-839 (1980).
4. S. Hara, J. Hagiwara, M. Fukuzawa, N. Ono, and T. Kuroda. Determination of phenytoin and its main metabolites in human serum by high-performance liquid chromatography with fluorescence detection. Anal. Sci. 15: 371-375 (1999).
5. P.M. Kabra and L.J. Marton. High-pressure liquid chromatographic determination of 5-(4-hydroxyphenyl)-5-phenylhydantoin in human urine. Clin. Chem. 22: 1672-1674 (1976).
6. M.J. Eadie. Therapeutic drug monitoring - antiepileptic drugs. Br. J. Clin. Pharmacol. 46: 185-193 (1998).
7. K.J. Lee, G.S. Heo, N.J. Kim, and D.C. Moon. Analysis of antiepileptic drugs in human plasma using micellar electrokinetic capillary chromatography. J. Chromatogr. A 608: 243-250 (1992).
8. J. Caslavska, S. Lienhard, and W. Thormann. Comparative use of three electrokinetic capillary methods for the determination of drugs in body fluids. Prospects for rapid determination of intoxications. J. Chromatogr. 638: 335-342 (1993).
9. A. Schmutz and W. Thormann. Determination of phenobarbital, ethosuximide, and primidone in human serum by micellar electrokinetic capillary chromatography with direct sample injection. Ther. Drug Monitor. 15: 310-316 (1993).
10. A. Schmutz and W. Thormann. Assessment of impact of physico-chemical drug properties on monitoring drug levels by micellar electrokinetic capillary chromatography with direct serum injection. Electrophoresis 15: 1295-1303 (1994).
11. K. Makino, Y. Goto, M. Sueyasu, K. Futagami, Y. Kataoka, and R. Oishi. Micellar electrokinetic capillary chromatography for therapeutic drug monitoring of zonisamide. J. Chromatogr. B 695: 417-425 (1997).
12. Y. Kataoka, K. Makino, and R. Oishi. Capillary electrophoresis for therapeutic drug monitoring of antiepileptics. Electrophoresis 19: 2856-2860 (1998).
13. R. Kuldvee and W. Thormann. Determination of carbamazepine and carbamazepine-10,11-epoxide in human serum and plasma by micellar electrokinetic capillary chromatography in the absence of electroosmosis. Electrophoresis 22: 1345-1355 (2001).
14. ICH Harmonised Tripartite Guideline, Q2 (R1), Validation of Analytical Procedures: Text and Methodology, 2005.